The global Ophthalmology Therapeutics market was valued at 144 million in 2024 and is projected to reach US$ 203 million by 2031, at a CAGR of 5.2% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ophthalmology Therapeutics manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Ophthalmology Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmology Therapeutics. This report contains market size and forecasts of Ophthalmology Therapeutics in global, including the following market information:
Global Ophthalmology Therapeutics market revenue, 2020-2025, 2026-2031, ($ millions)
Global Ophthalmology Therapeutics market sales, 2020-2025, 2026-2031, (K Units)
Global top five Ophthalmology Therapeutics companies in 2024 (%)
Total Market by Segment:
Global Ophthalmology Therapeutics market, by Type, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Ophthalmology Therapeutics market segment percentages, by Type, 2024 (%)
Gels
Eye Solutions
Capsules & Tablets
Ointments
Global Ophthalmology Therapeutics market, by Application, 2020-2025, 2026-2031 ($ Millions) & (K Units)
Global Ophthalmology Therapeutics market segment percentages, by Application, 2024 (%)
Glaucoma
Dry Eye Syndrome
Eye Infection
Other
Global Ophthalmology Therapeutics market, by region and country, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Ophthalmology Therapeutics market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ophthalmology Therapeutics revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Ophthalmology Therapeutics revenues share in global market, 2024 (%)
Key companies Ophthalmology Therapeutics sales in global market, 2020-2025 (estimated), (K Units)
Key companies Ophthalmology Therapeutics sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Aerie Pharmaceuticals
Bayer
F. Hoffmann-La Roche
Novartis AG
Otsuka Holdings
Pfizer
Regeneron Pharmaceuticals
Santen Pharmaceutical
Teva Pharmaceutical Industries
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ophthalmology Therapeutics, market overview.
Chapter 2: Global Ophthalmology Therapeutics market size in revenue and volume.
Chapter 3: Detailed analysis of Ophthalmology Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ophthalmology Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Ophthalmology Therapeutics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Ophthalmology Therapeutics Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Ophthalmology Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ophthalmology Therapeutics Overall Market Size
2.1 Global Ophthalmology Therapeutics Market Size: 2024 VS 2031
2.2 Global Ophthalmology Therapeutics Market Size, Prospects & Forecasts: 2020-2031
2.3 Global Ophthalmology Therapeutics Sales: 2020-2031
3 Company Landscape
3.1 Top Ophthalmology Therapeutics Players in Global Market
3.2 Top Global Ophthalmology Therapeutics Companies Ranked by Revenue
3.3 Global Ophthalmology Therapeutics Revenue by Companies
3.4 Global Ophthalmology Therapeutics Sales by Companies
3.5 Global Ophthalmology Therapeutics Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Ophthalmology Therapeutics Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Ophthalmology Therapeutics Product Type
3.8 Tier 1, Tier 2, and Tier 3 Ophthalmology Therapeutics Players in Global Market
3.8.1 List of Global Tier 1 Ophthalmology Therapeutics Companies
3.8.2 List of Global Tier 2 and Tier 3 Ophthalmology Therapeutics Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Ophthalmology Therapeutics Market Size Markets, 2024 & 2031
4.1.2 Gels
4.1.3 Eye Solutions
4.1.4 Capsules & Tablets
4.1.5 Ointments
4.2 Segment by Type - Global Ophthalmology Therapeutics Revenue & Forecasts
4.2.1 Segment by Type - Global Ophthalmology Therapeutics Revenue, 2020-2025
4.2.2 Segment by Type - Global Ophthalmology Therapeutics Revenue, 2026-2031
4.2.3 Segment by Type - Global Ophthalmology Therapeutics Revenue Market Share, 2020-2031
4.3 Segment by Type - Global Ophthalmology Therapeutics Sales & Forecasts
4.3.1 Segment by Type - Global Ophthalmology Therapeutics Sales, 2020-2025
4.3.2 Segment by Type - Global Ophthalmology Therapeutics Sales, 2026-2031
4.3.3 Segment by Type - Global Ophthalmology Therapeutics Sales Market Share, 2020-2031
4.4 Segment by Type - Global Ophthalmology Therapeutics Price (Manufacturers Selling Prices), 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Ophthalmology Therapeutics Market Size, 2024 & 2031
5.1.2 Glaucoma
5.1.3 Dry Eye Syndrome
5.1.4 Eye Infection
5.1.5 Other
5.2 Segment by Application - Global Ophthalmology Therapeutics Revenue & Forecasts
5.2.1 Segment by Application - Global Ophthalmology Therapeutics Revenue, 2020-2025
5.2.2 Segment by Application - Global Ophthalmology Therapeutics Revenue, 2026-2031
5.2.3 Segment by Application - Global Ophthalmology Therapeutics Revenue Market Share, 2020-2031
5.3 Segment by Application - Global Ophthalmology Therapeutics Sales & Forecasts
5.3.1 Segment by Application - Global Ophthalmology Therapeutics Sales, 2020-2025
5.3.2 Segment by Application - Global Ophthalmology Therapeutics Sales, 2026-2031
5.3.3 Segment by Application - Global Ophthalmology Therapeutics Sales Market Share, 2020-2031
5.4 Segment by Application - Global Ophthalmology Therapeutics Price (Manufacturers Selling Prices), 2020-2031
6 Sights by Region
6.1 By Region - Global Ophthalmology Therapeutics Market Size, 2024 & 2031
6.2 By Region - Global Ophthalmology Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Ophthalmology Therapeutics Revenue, 2020-2025
6.2.2 By Region - Global Ophthalmology Therapeutics Revenue, 2026-2031
6.2.3 By Region - Global Ophthalmology Therapeutics Revenue Market Share, 2020-2031
6.3 By Region - Global Ophthalmology Therapeutics Sales & Forecasts
6.3.1 By Region - Global Ophthalmology Therapeutics Sales, 2020-2025
6.3.2 By Region - Global Ophthalmology Therapeutics Sales, 2026-2031
6.3.3 By Region - Global Ophthalmology Therapeutics Sales Market Share, 2020-2031
6.4 North America
6.4.1 By Country - North America Ophthalmology Therapeutics Revenue, 2020-2031
6.4.2 By Country - North America Ophthalmology Therapeutics Sales, 2020-2031
6.4.3 United States Ophthalmology Therapeutics Market Size, 2020-2031
6.4.4 Canada Ophthalmology Therapeutics Market Size, 2020-2031
6.4.5 Mexico Ophthalmology Therapeutics Market Size, 2020-2031
6.5 Europe
6.5.1 By Country - Europe Ophthalmology Therapeutics Revenue, 2020-2031
6.5.2 By Country - Europe Ophthalmology Therapeutics Sales, 2020-2031
6.5.3 Germany Ophthalmology Therapeutics Market Size, 2020-2031
6.5.4 France Ophthalmology Therapeutics Market Size, 2020-2031
6.5.5 U.K. Ophthalmology Therapeutics Market Size, 2020-2031
6.5.6 Italy Ophthalmology Therapeutics Market Size, 2020-2031
6.5.7 Russia Ophthalmology Therapeutics Market Size, 2020-2031
6.5.8 Nordic Countries Ophthalmology Therapeutics Market Size, 2020-2031
6.5.9 Benelux Ophthalmology Therapeutics Market Size, 2020-2031
6.6 Asia
6.6.1 By Region - Asia Ophthalmology Therapeutics Revenue, 2020-2031
6.6.2 By Region - Asia Ophthalmology Therapeutics Sales, 2020-2031
6.6.3 China Ophthalmology Therapeutics Market Size, 2020-2031
6.6.4 Japan Ophthalmology Therapeutics Market Size, 2020-2031
6.6.5 South Korea Ophthalmology Therapeutics Market Size, 2020-2031
6.6.6 Southeast Asia Ophthalmology Therapeutics Market Size, 2020-2031
6.6.7 India Ophthalmology Therapeutics Market Size, 2020-2031
6.7 South America
6.7.1 By Country - South America Ophthalmology Therapeutics Revenue, 2020-2031
6.7.2 By Country - South America Ophthalmology Therapeutics Sales, 2020-2031
6.7.3 Brazil Ophthalmology Therapeutics Market Size, 2020-2031
6.7.4 Argentina Ophthalmology Therapeutics Market Size, 2020-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Ophthalmology Therapeutics Revenue, 2020-2031
6.8.2 By Country - Middle East & Africa Ophthalmology Therapeutics Sales, 2020-2031
6.8.3 Turkey Ophthalmology Therapeutics Market Size, 2020-2031
6.8.4 Israel Ophthalmology Therapeutics Market Size, 2020-2031
6.8.5 Saudi Arabia Ophthalmology Therapeutics Market Size, 2020-2031
6.8.6 UAE Ophthalmology Therapeutics Market Size, 2020-2031
7 Manufacturers & Brands Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Ophthalmology Therapeutics Major Product Offerings
7.1.4 AbbVie Ophthalmology Therapeutics Sales and Revenue in Global (2020-2025)
7.1.5 AbbVie Key News & Latest Developments
7.2 Aerie Pharmaceuticals
7.2.1 Aerie Pharmaceuticals Company Summary
7.2.2 Aerie Pharmaceuticals Business Overview
7.2.3 Aerie Pharmaceuticals Ophthalmology Therapeutics Major Product Offerings
7.2.4 Aerie Pharmaceuticals Ophthalmology Therapeutics Sales and Revenue in Global (2020-2025)
7.2.5 Aerie Pharmaceuticals Key News & Latest Developments
7.3 Bayer
7.3.1 Bayer Company Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Ophthalmology Therapeutics Major Product Offerings
7.3.4 Bayer Ophthalmology Therapeutics Sales and Revenue in Global (2020-2025)
7.3.5 Bayer Key News & Latest Developments
7.4 F. Hoffmann-La Roche
7.4.1 F. Hoffmann-La Roche Company Summary
7.4.2 F. Hoffmann-La Roche Business Overview
7.4.3 F. Hoffmann-La Roche Ophthalmology Therapeutics Major Product Offerings
7.4.4 F. Hoffmann-La Roche Ophthalmology Therapeutics Sales and Revenue in Global (2020-2025)
7.4.5 F. Hoffmann-La Roche Key News & Latest Developments
7.5 Novartis AG
7.5.1 Novartis AG Company Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Ophthalmology Therapeutics Major Product Offerings
7.5.4 Novartis AG Ophthalmology Therapeutics Sales and Revenue in Global (2020-2025)
7.5.5 Novartis AG Key News & Latest Developments
7.6 Otsuka Holdings
7.6.1 Otsuka Holdings Company Summary
7.6.2 Otsuka Holdings Business Overview
7.6.3 Otsuka Holdings Ophthalmology Therapeutics Major Product Offerings
7.6.4 Otsuka Holdings Ophthalmology Therapeutics Sales and Revenue in Global (2020-2025)
7.6.5 Otsuka Holdings Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Ophthalmology Therapeutics Major Product Offerings
7.7.4 Pfizer Ophthalmology Therapeutics Sales and Revenue in Global (2020-2025)
7.7.5 Pfizer Key News & Latest Developments
7.8 Regeneron Pharmaceuticals
7.8.1 Regeneron Pharmaceuticals Company Summary
7.8.2 Regeneron Pharmaceuticals Business Overview
7.8.3 Regeneron Pharmaceuticals Ophthalmology Therapeutics Major Product Offerings
7.8.4 Regeneron Pharmaceuticals Ophthalmology Therapeutics Sales and Revenue in Global (2020-2025)
7.8.5 Regeneron Pharmaceuticals Key News & Latest Developments
7.9 Santen Pharmaceutical
7.9.1 Santen Pharmaceutical Company Summary
7.9.2 Santen Pharmaceutical Business Overview
7.9.3 Santen Pharmaceutical Ophthalmology Therapeutics Major Product Offerings
7.9.4 Santen Pharmaceutical Ophthalmology Therapeutics Sales and Revenue in Global (2020-2025)
7.9.5 Santen Pharmaceutical Key News & Latest Developments
7.10 Teva Pharmaceutical Industries
7.10.1 Teva Pharmaceutical Industries Company Summary
7.10.2 Teva Pharmaceutical Industries Business Overview
7.10.3 Teva Pharmaceutical Industries Ophthalmology Therapeutics Major Product Offerings
7.10.4 Teva Pharmaceutical Industries Ophthalmology Therapeutics Sales and Revenue in Global (2020-2025)
7.10.5 Teva Pharmaceutical Industries Key News & Latest Developments
8 Global Ophthalmology Therapeutics Production Capacity, Analysis
8.1 Global Ophthalmology Therapeutics Production Capacity, 2020-2031
8.2 Ophthalmology Therapeutics Production Capacity of Key Manufacturers in Global Market
8.3 Global Ophthalmology Therapeutics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Ophthalmology Therapeutics Supply Chain Analysis
10.1 Ophthalmology Therapeutics Industry Value Chain
10.2 Ophthalmology Therapeutics Upstream Market
10.3 Ophthalmology Therapeutics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Ophthalmology Therapeutics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Ophthalmology Therapeutics in Global Market
Table 2. Top Ophthalmology Therapeutics Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Ophthalmology Therapeutics Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Ophthalmology Therapeutics Revenue Share by Companies, 2020-2025
Table 5. Global Ophthalmology Therapeutics Sales by Companies, (K Units), 2020-2025
Table 6. Global Ophthalmology Therapeutics Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Ophthalmology Therapeutics Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Ophthalmology Therapeutics Product Type
Table 9. List of Global Tier 1 Ophthalmology Therapeutics Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ophthalmology Therapeutics Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type – Global Ophthalmology Therapeutics Revenue, (US$, Mn), 2024 & 2031
Table 12. Segment by Type - Global Ophthalmology Therapeutics Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Ophthalmology Therapeutics Revenue (US$, Mn), 2026-2031
Table 14. Segment by Type - Global Ophthalmology Therapeutics Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Ophthalmology Therapeutics Sales (K Units), 2026-2031
Table 16. Segment by Application – Global Ophthalmology Therapeutics Revenue, (US$, Mn), 2024 & 2031
Table 17. Segment by Application - Global Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Ophthalmology Therapeutics Revenue, (US$, Mn), 2026-2031
Table 19. Segment by Application - Global Ophthalmology Therapeutics Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Ophthalmology Therapeutics Sales, (K Units), 2026-2031
Table 21. By Region – Global Ophthalmology Therapeutics Revenue, (US$, Mn), 2025-2031
Table 22. By Region - Global Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Ophthalmology Therapeutics Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Global Ophthalmology Therapeutics Sales, (K Units), 2020-2025
Table 25. By Region - Global Ophthalmology Therapeutics Sales, (K Units), 2026-2031
Table 26. By Country - North America Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Ophthalmology Therapeutics Revenue, (US$, Mn), 2026-2031
Table 28. By Country - North America Ophthalmology Therapeutics Sales, (K Units), 2020-2025
Table 29. By Country - North America Ophthalmology Therapeutics Sales, (K Units), 2026-2031
Table 30. By Country - Europe Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Ophthalmology Therapeutics Revenue, (US$, Mn), 2026-2031
Table 32. By Country - Europe Ophthalmology Therapeutics Sales, (K Units), 2020-2025
Table 33. By Country - Europe Ophthalmology Therapeutics Sales, (K Units), 2026-2031
Table 34. By Region - Asia Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Ophthalmology Therapeutics Revenue, (US$, Mn), 2026-2031
Table 36. By Region - Asia Ophthalmology Therapeutics Sales, (K Units), 2020-2025
Table 37. By Region - Asia Ophthalmology Therapeutics Sales, (K Units), 2026-2031
Table 38. By Country - South America Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Ophthalmology Therapeutics Revenue, (US$, Mn), 2026-2031
Table 40. By Country - South America Ophthalmology Therapeutics Sales, (K Units), 2020-2025
Table 41. By Country - South America Ophthalmology Therapeutics Sales, (K Units), 2026-2031
Table 42. By Country - Middle East & Africa Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Ophthalmology Therapeutics Revenue, (US$, Mn), 2026-2031
Table 44. By Country - Middle East & Africa Ophthalmology Therapeutics Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Ophthalmology Therapeutics Sales, (K Units), 2026-2031
Table 46. AbbVie Company Summary
Table 47. AbbVie Ophthalmology Therapeutics Product Offerings
Table 48. AbbVie Ophthalmology Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. AbbVie Key News & Latest Developments
Table 50. Aerie Pharmaceuticals Company Summary
Table 51. Aerie Pharmaceuticals Ophthalmology Therapeutics Product Offerings
Table 52. Aerie Pharmaceuticals Ophthalmology Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. Aerie Pharmaceuticals Key News & Latest Developments
Table 54. Bayer Company Summary
Table 55. Bayer Ophthalmology Therapeutics Product Offerings
Table 56. Bayer Ophthalmology Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Bayer Key News & Latest Developments
Table 58. F. Hoffmann-La Roche Company Summary
Table 59. F. Hoffmann-La Roche Ophthalmology Therapeutics Product Offerings
Table 60. F. Hoffmann-La Roche Ophthalmology Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. F. Hoffmann-La Roche Key News & Latest Developments
Table 62. Novartis AG Company Summary
Table 63. Novartis AG Ophthalmology Therapeutics Product Offerings
Table 64. Novartis AG Ophthalmology Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. Novartis AG Key News & Latest Developments
Table 66. Otsuka Holdings Company Summary
Table 67. Otsuka Holdings Ophthalmology Therapeutics Product Offerings
Table 68. Otsuka Holdings Ophthalmology Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Otsuka Holdings Key News & Latest Developments
Table 70. Pfizer Company Summary
Table 71. Pfizer Ophthalmology Therapeutics Product Offerings
Table 72. Pfizer Ophthalmology Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. Pfizer Key News & Latest Developments
Table 74. Regeneron Pharmaceuticals Company Summary
Table 75. Regeneron Pharmaceuticals Ophthalmology Therapeutics Product Offerings
Table 76. Regeneron Pharmaceuticals Ophthalmology Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 77. Regeneron Pharmaceuticals Key News & Latest Developments
Table 78. Santen Pharmaceutical Company Summary
Table 79. Santen Pharmaceutical Ophthalmology Therapeutics Product Offerings
Table 80. Santen Pharmaceutical Ophthalmology Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 81. Santen Pharmaceutical Key News & Latest Developments
Table 82. Teva Pharmaceutical Industries Company Summary
Table 83. Teva Pharmaceutical Industries Ophthalmology Therapeutics Product Offerings
Table 84. Teva Pharmaceutical Industries Ophthalmology Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 85. Teva Pharmaceutical Industries Key News & Latest Developments
Table 86. Ophthalmology Therapeutics Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 87. Global Ophthalmology Therapeutics Capacity Market Share of Key Manufacturers, 2023-2025
Table 88. Global Ophthalmology Therapeutics Production by Region, 2020-2025 (K Units)
Table 89. Global Ophthalmology Therapeutics Production by Region, 2026-2031 (K Units)
Table 90. Ophthalmology Therapeutics Market Opportunities & Trends in Global Market
Table 91. Ophthalmology Therapeutics Market Drivers in Global Market
Table 92. Ophthalmology Therapeutics Market Restraints in Global Market
Table 93. Ophthalmology Therapeutics Raw Materials
Table 94. Ophthalmology Therapeutics Raw Materials Suppliers in Global Market
Table 95. Typical Ophthalmology Therapeutics Downstream
Table 96. Ophthalmology Therapeutics Downstream Clients in Global Market
Table 97. Ophthalmology Therapeutics Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Ophthalmology Therapeutics Product Picture
Figure 2. Ophthalmology Therapeutics Segment by Type in 2024
Figure 3. Ophthalmology Therapeutics Segment by Application in 2024
Figure 4. Global Ophthalmology Therapeutics Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Ophthalmology Therapeutics Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Ophthalmology Therapeutics Revenue: 2020-2031 (US$, Mn)
Figure 8. Ophthalmology Therapeutics Sales in Global Market: 2020-2031 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Ophthalmology Therapeutics Revenue in 2024
Figure 10. Segment by Type – Global Ophthalmology Therapeutics Revenue, (US$, Mn), 2024 & 2031
Figure 11. Segment by Type - Global Ophthalmology Therapeutics Revenue Market Share, 2020-2031
Figure 12. Segment by Type - Global Ophthalmology Therapeutics Sales Market Share, 2020-2031
Figure 13. Segment by Type - Global Ophthalmology Therapeutics Price (US$/Unit), 2020-2031
Figure 14. Segment by Application – Global Ophthalmology Therapeutics Revenue, (US$, Mn), 2024 & 2031
Figure 15. Segment by Application - Global Ophthalmology Therapeutics Revenue Market Share, 2020-2031
Figure 16. Segment by Application - Global Ophthalmology Therapeutics Sales Market Share, 2020-2031
Figure 17. Segment by Application -Global Ophthalmology Therapeutics Price (US$/Unit), 2020-2031
Figure 18. By Region – Global Ophthalmology Therapeutics Revenue, (US$, Mn), 2025 & 2031
Figure 19. By Region - Global Ophthalmology Therapeutics Revenue Market Share, 2020 VS 2024 VS 2031
Figure 20. By Region - Global Ophthalmology Therapeutics Revenue Market Share, 2020-2031
Figure 21. By Region - Global Ophthalmology Therapeutics Sales Market Share, 2020-2031
Figure 22. By Country - North America Ophthalmology Therapeutics Revenue Market Share, 2020-2031
Figure 23. By Country - North America Ophthalmology Therapeutics Sales Market Share, 2020-2031
Figure 24. United States Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2031
Figure 25. Canada Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2031
Figure 26. Mexico Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2031
Figure 27. By Country - Europe Ophthalmology Therapeutics Revenue Market Share, 2020-2031
Figure 28. By Country - Europe Ophthalmology Therapeutics Sales Market Share, 2020-2031
Figure 29. Germany Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2031
Figure 30. France Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2031
Figure 31. U.K. Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2031
Figure 32. Italy Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2031
Figure 33. Russia Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2031
Figure 34. Nordic Countries Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2031
Figure 35. Benelux Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2031
Figure 36. By Region - Asia Ophthalmology Therapeutics Revenue Market Share, 2020-2031
Figure 37. By Region - Asia Ophthalmology Therapeutics Sales Market Share, 2020-2031
Figure 38. China Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2031
Figure 39. Japan Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2031
Figure 40. South Korea Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2031
Figure 41. Southeast Asia Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2031
Figure 42. India Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2031
Figure 43. By Country - South America Ophthalmology Therapeutics Revenue Market Share, 2020-2031
Figure 44. By Country - South America Ophthalmology Therapeutics Sales, Market Share, 2020-2031
Figure 45. Brazil Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2031
Figure 46. Argentina Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2031
Figure 47. By Country - Middle East & Africa Ophthalmology Therapeutics Revenue, Market Share, 2020-2031
Figure 48. By Country - Middle East & Africa Ophthalmology Therapeutics Sales, Market Share, 2020-2031
Figure 49. Turkey Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2031
Figure 50. Israel Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2031
Figure 51. Saudi Arabia Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2031
Figure 52. UAE Ophthalmology Therapeutics Revenue, (US$, Mn), 2020-2031
Figure 53. Global Ophthalmology Therapeutics Production Capacity (K Units), 2020-2031
Figure 54. The Percentage of Production Ophthalmology Therapeutics by Region, 2024 VS 2031
Figure 55. Ophthalmology Therapeutics Industry Value Chain
Figure 56. Marketing Channels
